Digest Network Come funziona
Network
/
Società
BP
Non verificato

BPGbio, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

19 comunicati stampa

Guarda tutti i comunicati
20/03/2025
Eventi
Industria
Tecnica
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Oncologia
BPGbio to Present Novel E2-based Targeted Protein Degradation Program at 5th Annual TPD and Induced Proximity Summit in Europe
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
22/01/2025
Industria
Eventi
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
BPGbio Unveils Research on the Identification of Novel Pancreatic Cancer Patient Subtypes at ASCO GI 2025 Paving the Way for Tailored Treatment
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
21/11/2024
Scienza
Tecnica
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Oncologia
Eventi
Industria
BPGbio to Present New Data on Novel Glioblastoma Therapies at SNO 2024
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
07/11/2024
Eventi
Biotecnologia
Farmaceutica
Oncologia
Salute
Tecnica
Medicina - Varie
BPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and BRG399 at SITC 2024
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
31/10/2024
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
CORRECTING and REPLACING BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
31/10/2024
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
BPGbio Receives FDA Rare Pediatric Disease Designation for its Investigational Treatment for Epidermolysis Bullosa
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
28/10/2024
Eventi
Software
Scienza
Farmaceutica
Oncologia
Tecnica
Medicina - Varie
Biotecnologia
Salute
BPGbio CEO Niven R. Narain to Present at Google’s Inaugural Cancer AI Symposium
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
24/10/2024
Eventi
Industria
Software
Biotecnologia
Farmaceutica
Salute
Tecnica
Medicina - Varie
BPGbio to Present Novel E2-based Targeted Protein Degradation Program at TPD and Induced Proximity Summit
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
23/10/2024
Eventi
Industria
Biotecnologia
Tecnica
Salute
Farmaceutica
Oncologia
Scienza
Medicina - Varie
BPGbio to Present New Data on BPM31510 and Novel Quinomics Technology for Treatment of Primary CoQ10 Deficiency at MitoCon 2024
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0
15/10/2024
Eventi
Fiere
Industria
Tecnica
Biotecnologia
Salute
Farmaceutica
Oncologia
Scienza
Software
Sanità
Medicina - Varie
BPGbio to Present on E2-based Approach to Targeted Protein Degradation at US Pharma Partnering Summit
Fonte
BPGbio, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0